New Research Links GLP-1 Agonists to NAION A study published in JAMA Ophthalmology on July 3, 2024, found that type 2 diabetes patients prescribed GLP-1 agonists were at an increased risk for developing a rare and debilitating eye condition called NAION
N Engl J Med 359(15):15771589 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, EXSCEL Study Group et al (2017) Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Propionil-L-carnitina : questa forma adatta per problemi circolatori, come la malattia vascolare periferica e lipertensione
J Endocrinol Invest 16:129-131, 1993
Simultaneously, we also detected the transcriptional expression of some other factors in the Wnt/-Catenin signaling pathway
Another important effect is appetite control